Johnson & Johnson (JNJ)
158.24
-1.89
(-1.18%)
USD |
NYSE |
Nov 04, 16:00
158.42
+0.18
(+0.11%)
Pre-Market: 06:34
Johnson & Johnson Cash from Investing (Quarterly): -3.128B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.128B |
| June 30, 2024 | -13.69B |
| March 31, 2024 | -464.00M |
| December 31, 2023 | -1.202B |
| September 30, 2023 | 2.541B |
| June 30, 2023 | -3.776B |
| March 31, 2023 | 3.315B |
| December 31, 2022 | -4.397B |
| September 30, 2022 | -1.701B |
| June 30, 2022 | -2.639B |
| March 31, 2022 | -3.634B |
| December 31, 2021 | -5.36B |
| September 30, 2021 | -2.719B |
| June 30, 2021 | -419.00M |
| March 31, 2021 | -185.00M |
| December 31, 2020 | -7.903B |
| September 30, 2020 | -4.819B |
| June 30, 2020 | -7.522B |
| March 31, 2020 | -581.00M |
| December 31, 2019 | -1.344B |
| September 30, 2019 | -1.645B |
| June 30, 2019 | -1.788B |
| March 31, 2019 | -1.417B |
| December 31, 2018 | 2.228B |
| September 30, 2018 | -4.269B |
| Date | Value |
|---|---|
| June 30, 2018 | -201.00M |
| March 31, 2018 | -925.00M |
| December 31, 2017 | -505.00M |
| September 30, 2017 | -1.18B |
| June 30, 2017 | -12.25B |
| March 31, 2017 | -936.00M |
| December 31, 2016 | -2.174B |
| September 30, 2016 | -2.372B |
| June 30, 2016 | 1.322B |
| March 31, 2016 | -1.537B |
| December 31, 2015 | -1.391B |
| September 30, 2015 | -1.001B |
| June 30, 2015 | -3.554B |
| March 31, 2015 | -1.789B |
| December 31, 2014 | -2.922B |
| September 30, 2014 | 735.00M |
| June 30, 2014 | -8.092B |
| March 31, 2014 | -2.026B |
| December 31, 2013 | -1.578B |
| September 30, 2013 | -1.553B |
| June 30, 2013 | -569.00M |
| March 31, 2013 | -1.403B |
| December 31, 2012 | -2.503B |
| September 30, 2012 | -1.937B |
| June 30, 2012 | -4.126B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-13.69B
Minimum
Jun 2024
3.315B
Maximum
Mar 2023
-2.981B
Average
-2.679B
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -1.069B |
| Pfizer Inc | 4.60B |
| AbbVie Inc | -8.256B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.993B |
| Cash from Financing (Quarterly) | -9.882B |
| Free Cash Flow | 19.02B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 11.45B |
| Free Cash Flow to Firm (Quarterly) | 5.714B |
| Free Cash Flow Yield | 4.95% |